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Abstract
Background:  Nanog, nucleostemin (NS) and musashi1 (Msi1) are proteins that are highly
expressed in undifferentiated embryonic stem (ES) cells and have been shown to be essential in
maintaining the pluripotency and regulating the proliferation and asymmetric division of ES cells and
several nervous system tumor cells. The roles of Nanog, NS and Msi1 in development and
progression of cervical carcinoma have, until now, not been well documented.
Methods: In this study, expression of Nanog, NS and Msi1 was detected by immunohistochemistry
analysis in 235 patients with various degrees of cervical epithelial lesions, including 49 with normal
cervical epithelia, 31 with mild dysplasia (CIN I), 77 with moderate-severe dysplasia (CIN II-III) and
78 with squamous cervical carcinomas (SCCs). Associations with various clinical pathological
prognostic variables were analyzed in 50 early-stage SCC patients.
Results: Nanog, NS and Msi1 expression levels were significantly higher in SCC patients compared
with CIN patients, and were higher in CIN patients compared with those with normal cervical
epithelia. Nanog expression levels showed significantly differences according to different tumor
sizes (P < 0.05), whereas there were no differences in NS and Msi1 expression levels according to
different clinical pathological parameters.
Conclusion: Our findings indicate that Nanog, NS and Msi1 may be involved in carcinogenesis of
the cervix and progression of cervical carcinoma.
Background
The stem-cell-abundant proteins Nanog, nucleostemin
(NS) and Musashi1 (Msi1) are highly expressed in undif-
ferentiated embryonic stem cells, and regulate stem-cell
differentiation, proliferation and asymmetric division,
respectively. Nanog is a unique homeobox transcription
factor and has a homeodomain with homology to mem-
bers of the natural killer (NK) gene family[1]; indeed, it
has a similar critical role in regulating the cell fate of the
pluripotent ICM (inner cell mass) during embryonic
development, maintaining the pluripotent epiblast and
preventing differentiation [2,3]. NS is a putative GTPase
that binds to P53 and is highly expressed in the nucleoli
of neuronal and embryonic stem cells, and several cancer
cell lines. NS is essential for stem- and cancer-cell prolifer-
ation [4]. Msi1 is an RNA-binding protein that is abun-
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dantly expressed in neural stem/progenitor cells,
astroglial progenitor cells and astrocytes in the vertebrate
central nervous system[5] and regulates the expression of
its target gene, mammalian numb (m-numb), at the trans-
lational level and is associated with asymmetric cell divi-
sion in neural progenitor cells[6]. These three proteins
may have roles in carcinogenesis of embryonic cancer
(EC), gliomas, liver cancer, gastric cancer, and other can-
cers[7-9]. The roles of these proteins in the transformation
of cervical epithelial cells and the occurrence and develop-
ment of cervical carcinoma have not previously been
investigated.
In this study, we examined the expression of Nanog, NS
and Msi1 in cervical epithelial lesions of varying severity
and in cervical carcinomas by immunohistochemical




The specimens (n = 235) were obtained from patients at
the Women's Hospital, School of Medicine, Zhejiang Uni-
versity from October 2004 to June 2005. Of these 235
patients, 49 had normal cervical epithelia, 31 had mild
dysplasia (CINI), 77 had moderate-severe dysplasia (CIN
II-III) and 78 had squamous cervical carcinomas (SCC).
None of the patients had recevied chemotherapy, immu-
notherapy, or radiotherapy prior to specimen collection.
Of the 78 SCC patients, 50 were diagnosed with early-
stage SCC (including 10 Ia, 38 Ib and 2 IIa patients) and
underwent radical hysterectomy and pelvic lymphadenec-
tomy. The other 28 patients were diagnosed with stage >
IIa SCC.
This study was approved by the Medical Ethical Commit-
tee of Women's Hospital, School of Medicine, Zhejiang
University. All patients signed informed consent to allow
molecular research on specimen obtained during surgical
operation.
Primary Antibodies
The goat anti-human polyclonal antibodies specific for
Nanog, NS and Msi1 were purchased from R&D (USA).
Immunohistochemistry and Evaluation
Following sample collection, all tissues were immediately
fixed in 10% neutralized formalin for 24 hours prior to
transfer to paraffin wax using standard procedures. Paraf-
fin sections (4 μm) were used for histological diagnosis or
immunohistochemical analysis. Tissue sections were
dewaxed and rehydrated using standard procedures.
Hydrated autoclave pretreatment involved boiling for 2
minutes in 10 mM citrate buffer (pH 6.0). After cooling
(20 minutes at room temperature), the sections were
immersed in 3% hydrogen peroxide (H2O2) for 10 min-
utes to block endogenous peroxidase activity. Nonspecific
staining was prevented by 10-minute incubation with
normal rabbit serum (Maixin, China). Excess normal
serum was removed and replaced with the primary anti-
body (Nanog antibody, 5 μg/ml; NS antibody, 5 μg/ml;
Msi1 antibody, 10 μg/ml) and incubated for 2 hours in a
humid chamber at room temperature. After washing, the
sections were incubated with biotin-labeled anti-goat sec-
ondary antibody followed by avidin-biotin complex
(ABC) for 30 minutes. These reagents were purchased
from Maixin Corp. 3,3'-diaminobenzidine tetrahydro-
chloride (Dako, Germany) was added to visualize the
reaction. Slides were washed three times (5 minutes each
time) in phosphate-buffered saline (PBS)-Tween between
each step. The slides were then counterstained with
Mayer's hematoxylin, rinsed with tap water, dehydrated,
placed in xylene, and mounted. Blank controls were per-
formed by replacing primary antibodies with normal goat
serum.
Positive cells were indicated by the presence of a distinct
brown color in the nucleus or cytoplasm. The number of
positively stained cells out of 100 in 10 random fields
(400× objective) was counted and reported as the percent-
age of the total number of cells. The semiquantitative
immunoreactive score ranged from - (0) to +++ (3) based
on the percentage of positive cells and the stain intensity:
- (0) = < 5% positive cells; +(1) = 5–25% positive cells;
++(2) = 26–75% positive cells; and +++(3) = more than
76% positive cells. Slides were independently reviewed by
two pathologists and consensus agreements were reached.
Statistics
The Kruskal-Wallis H test and the Mann-Whitney U test
were performed using SPSS 13.0 software package for
Windows. A level of 0.05 was chosen to indicate statistical
significance. All reported P values were bilateral.
Results
In CIN II-III and cervical carcinoma tissues, Nanog, NS
and Msi1 were moderately or strongly expressed, in con-
trast to low expression levels in normal cervical epithelia
and CIN I cells. All blank controls showed negative immu-
nostaining results. The distinct brown color indicative of
Nanog, NS and Msi1 expression was detected in the cyto-
plasm, nucleus and cytoplasm, respectively, of the posi-
tive cells.
Expression levels of Nanog, NS and Msi1 were higher in
samples from SCC patients than in samples from patients
with normal cervical epithelia and CIN; they were also
higher in samples from patients with CIN than from thoseBMC Cancer 2008, 8:108 http://www.biomedcentral.com/1471-2407/8/108
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with normal cervical epithelia (Table 1). Typical staining
of normal, CIN and SCC samples are shown in Figures 1,
2 and 3, respectively.
Associations between Nanog, NS and Msi1 expression lev-
els and clinical pathological prognostic factors (such as
age, clinical stage, tumor size, invasive depth, lymph
nodes metastasis; lymph-vascular space invasion in para-
metrial tissues and differentiation, et al) were analyzed in
samples from 50 early-stage SCC patients undergoing sur-
gery. Only Nanog expression levels showed significant dif-
ferences according to different tumor sizes (P = 0.049); NS
and Msi1 expression levels showed no significant associa-
tions with the clinical pathological parameters analyzed
(data not shown).
Discussion
Nanog has an important role in regulating the cell fate of
the pluripotent ICM during embryonic development,
maintaining the pluripotent epiblast and preventing dif-
ferentiation [2,3]. Nanog is also one of the key down-
stream effectors of several extrinsic signals that support
the self-renewal and pluripotency of ES cells[10].
Increased levels of Nanog can maintain the mouse ES cell
self-renewal ability independent of LIF (leukemia inhibi-
tory factor) and allow human ES cell growth in the
absence feeder cells[11]. Nanog is enriched in pluripotent
cell lines such as ES, embryonic germ and EC cells, but it
is not expressed in adult tissues; its expression is downreg-
ulated in differentiation tissues[12,13].
Nucleostemin expression and localization in (A) normal cer- vical epithelial cells; (B) CINI cells; (C) CINIII cells; (D) SCC  cells Figure 2
Nucleostemin expression and localization in (A) nor-
mal cervical epithelial cells; (B) CINI cells; (C) CINIII 
cells; (D) SCC cells. The distinct brown coloration is 
located in the nucleus or the cytoplasm of the positive cells 
(400×).





























Normal 49 17 22 8 2 0.000† 16 22 8 3 0.000†† 15 25 7 2 0.000†††
CINI 31 2 18 9 2 0.009* 4 12 15 0 0.017§ 3 1 31 410.003¶
CINII-III 77 4 25 35 13 0.015** 2 23 39 13 0.008§§ 2 2 83 01 7 0.039¶¶
S C C 7 83 2 02 43 10.017**
*
11 3 4 3 2 1 0.026§§§ 1 2 02 53 1 0.032¶¶¶
† P value of four groups, Chi-square = 49.720.
†† P value of four groups, Chi-square = 55.325.
††† P value of four groups, Chi-square = 51.013.
* Normal vs CINI, Z = -2.616;
** CINI vs CINII-III, Z = -2.429;
*** CINII-III vs SCC, Z = -2.397.
§Normal vs CINI, Z = -2.379;
§§ CINI vs CINII-III, Z = -2.669;
§§§CINII-III vs SCC, Z = -2.231.
¶Normal vs CINI, Z = -2.949;
¶¶ CINI vs CINII-III, Z = -2.064;
¶¶¶CINII-III vs SCC, Z = -2.146.
Nanog expression and localization in (A) normal cervical epi- thelial cells; (B) CINI cells; (C) CINIII cell; (D) SCC cells Figure 1
Nanog expression and localization in (A) normal cer-
vical epithelial cells; (B) CINI cells; (C) CINIII cell; 
(D) SCC cells. The distinct brown coloration is located in 
the cytoplasm of the positive cells (400×).BMC Cancer 2008, 8:108 http://www.biomedcentral.com/1471-2407/8/108
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NS expression was closely associated with cellular prolif-
eration in normal fibroblasts, T lymphocytes, bone mar-
row stem cells (BMCs), human placenta tissue, renal cell
carcinoma cell lines and malignant renal tissues; but in
terminally differentiated normal human adult kidney and
mammary gland tissues, no NS expression could be
detected [14,15]. It is likely to be a proliferation marker
rather than a unique regulator of cell proliferation and
survival in stem and cancer cells. In addition, Han et al
reported that NS may have an important role in both tum-
origenesis and the transformation of human embryonic
bone marrow mesenchymal stem cells into F6 tumor cells
because NS expression levels were markedly high in F6
cells [16]. Sijin et al showed that NS expression is required
for HeLa cells to complete DNA synthesis and progress
through S-phase: knockdown of NS expression led to
increased numbers of HeLa cells in G0/G1 phase and the
cell proliferation rate and in vivo tumorigenic capacity
reduced markedly [17].
Msi1 is involved in maintenance of the character of pro-
genitor cells, has an important role in regulating cell dif-
ferentiation in precursor cells and is an evolutionarily
well-conserved marker for neural stem cells and progeni-
tor cells. Msi1 is an excellent marker for neural progenitor
cells including neural stem cells in normal human brains
[5]. Recently, Msi1 expression has been detected in
human gliomas and melanomas, indicating it may be
involved in oncogenic development. Tumors with high
levels of Msi1 expression tended to have high levels of
proliferative activity. Thus, the expression of Msi1 seems
to be correlated with the grade of the malignancy and pro-
liferative activity of gliomas, Msi1 may be a useful marker
for the diagnosis of central nervous system tumors [7,18].
Shu  et al detected the Msi1 protein in several human
hepatoma cell lines, indicating that Msi1 expression may
be an important factor in the development of several types
of carcinoma and may be a useful molecular marker for
tumor detection and diagnosis[8].
In our study, the distinct brown coloration indicative of
Nanog, NS and Msi1 were located in the cytoplasm,
nucleus and the cytoplasm, respectively, of the positive
cells. Localization os NS and Msi1 were in accordance
with previous reports; however, some reports have indi-
cated that Nanog is localized to the nucleus. In the present
study, we repeated the experiment and excluded the pos-
sibility of false-positive staining, and confirmed that
Nanog protein was consistently localized to the cyto-
plasm. The mechanism by which localization occurs is
unknown and further study is required.
There is an association among Nanog, NS and Msi1
expression levels and the severity of epithelial cell
changes, with expression levels highest in cells from SCC,
CIN and then normal cervical epithelium. However, there
were no positive correlations among Nanog, NS and Msi1
expression levels and the clinical pathological prognostic
factors analyzed, indicating that overexpression of these
three stem-cell-abundant proteins in cervical epithlium is
not related to the prognosis of cervical carcinoma[19].
Taken together, our results indicate that these three stem-
cell-abundant proteins (Nanog, NS and Msi1 have roles in
the carcinogenesis of cervical epithelial cells and regulate
the cell differentiation, proliferation and asymmetric divi-
sion, and maintain cancer cell pluripotency. Each protein
may have an important and unique role in each step of the
transformation process from normal cervical epithelial
cells to malignant cells. Determining the molecules
involved in tumorigenesis and development of cervical
carcinoma is important for the study of this disease. Inhi-
bition of the molecules important in the procession of
tumor cell transformation may block the tumorigenesis of
cervical carcinoma, and could have a clinical role in cervi-
cal carcinoma treatment; however, further study is
needed.
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